YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer
Xifan Wang(Nanjing University), Yu’an Hu(Nanjing General Hospital of Nanjing Military Command), Xiaoqing Li(Nanjing Traditional Chinese Medicine Hospital), Chuandong Zhu(Nanjing University of Chinese Medicine), Fangfang Chen(Jinling Institute of Technology)
Cited by 14Open Access
Abstract
Background: in controlling cisplatin resistance in non-small cell lung cancer (NSCLC). Methods: was clarified by m6A-immunoprecipitation-PCR (m6A-IP-PCR) assay. Results: mRNA. Conclusions: requires modifications to m6A, which ultimately inhibit cisplatin resistance in NSCLC.
Related Papers
No related papers found
Powered by citation graph analysis